Tag | Content |
---|---|
UniProt Accession | ADDA_HUMAN; P35611; |
Entrez ID | 118 |
GenBank Protein ID | NM_001119.4; NM_001286645.1; NM_014189.3; NM_014190.3; NM_176801.2; XM_005247937.2; XM_017007704.1; XM_017007706.1; XM_017007707.1; XM_017007708.1; XM_017007709.1; XM_017007710.1; |
GenBank Nucleotide ID | NP_001110.2; NP_001273574.1; NP_054908.2; NP_054909.2; NP_789771.1; XP_005247994.1; XP_016863193.1; XP_016863195.1; XP_016863196.1; XP_016863197.1; XP_016863198.1; XP_016863199.1; |
Protein Name | Alpha-adducin (Erythrocyte adducin subunit alpha) |
Gene Name | ADD1; ADDA |
Organism | Homo sapiens |
NCBI Taxa ID | 9606 |
Functional Description | Membrane-cytoskeleton-associated protein that promotes the assembly of the spectrin-actin network. Binds to calmodulin. |
Sequence (Fasta) | MNGDSRAAVV TSPPPTTAPH KERYFDRVDE NNPEYLRERN MAPDLRQDFN MMEQKKRVSM 60 ILQSPAFCEE LESMIQEQFK KGKNPTGLLA LQQIADFMTT NVPNVYPAAP QGGMAALNMS 120 LGMVTPVNDL RGSDSIAYDK GEKLLRCKLA AFYRLADLFG WSQLIYNHIT TRVNSEQEHF 180 LIVPFGLLYS EVTASSLVKI NLQGDIVDRG STNLGVNQAG FTLHSAIYAA RPDVKCVVHI 240 HTPAGAAVSA MKCGLLPISP EALSLGEVAY HDYHGILVDE EEKVLIQKNL GPKSKVLILR 300 NHGLVSVGES VEEAFYYIHN LVVACEIQVR TLASAGGPDN LVLLNPEKYK AKSRSPGSPV 360 GEGTGSPPKW QIGEQEFEAL MRMLDNLGYR TGYPYRYPAL REKSKKYSDV EVPASVTGYS 420 FASDGDSGTC SPLRHSFQKQ QREKTRWLNS GRGDEASEEG QNGSSPKSKT KWTKEDGHRT 480 STSAVPNLFV PLNTNPKEVQ EMRNKIREQN LQDIKTAGPQ SQVLCGVVMD RSLVQGELVT 540 ASKAIIEKEY QPHVIVSTTG PNPFTTLTDR ELEEYRREVE RKQKGSEENL DEAREQKEKS 600 PPDQPAVPHP PPSTPIKLEE DLVPEPTTGD DSDAATFKPT LPDLSPDEPS EALGFPMLEK 660 EEEAHRPPSP TEAPTEASPE PAPDPAPVAE EAAPSAVEEG AAADPGSDGS PGKSPSKKKK 720 KFRTPSFLKK SKKKSDS 738 |
|
Database | Annotation |
---|---|
CTD (Curated) (count: 2) | MESH:D006528
; Carcinoma, Hepatocellular MESH:D006973 ; Hypertension |
DisGeNet (Curated) (count: 3) | C0020538; Hypertensive disease
C0085580; Essential Hypertension C2239176; Liver carcinoma |
HGMD (count: 1) | CM021240; Hypertension, association with; Missense/nonsense
|
GWASdb (count: 14) (view all) | rs624833; Stroke; cerebrovascular disease
rs10488838; Alcohol consumption; alcohol abuse|alcohol dependence rs3775068; Coronary heart disease; coronary artery disease rs3775068; Cognitive impairment induced by topiramate; cognitive disorder rs17777307; Multiple complex diseases; Null rs2285084; Birth weight; end stage renal failure|type 2 diabetes mellitus|cardiovascular system disease |
PTM | Modification Sites |
---|---|
Phosphorylation (count: 59) (view all) | 11 DSRAAVVTSPPPTTA dbPAF
12 SRAAVVTSPPPTTAP dbPAF 16 VVTSPPPTTAPHKER dbPAF 17 VTSPPPTTAPHKERY dbPAF 24 TAPHKERYFDRVDEN dbPAF 331 ACEIQVRTLASAGGP dbPAF |
Acetylation (count: 3) | 140 SDSIAYDKGEKLLRC PLMD
143 IAYDKGEKLLRCKLA PLMD 543 GELVTASKAIIEKEY PLMD |
Ubiquitination (count: 13) (view all) | 140 SDSIAYDKGEKLLRC PLMD
143 IAYDKGEKLLRCKLA PLMD 148 GEKLLRCKLAAFYRL PLMD 21 PPTTAPHKERYFDRV PLMD 288 EEKVLIQKNLGPKSK PLMD 348 LVLLNPEKYKAKSRS PLMD |
Glycation (count: 3) | 140 SDSIAYDKGEKLLRC PLMD
143 IAYDKGEKLLRCKLA PLMD 235 YAARPDVKCVVHIHT PLMD |
Network | Interaction | ||
---|---|---|---|
A | B | Source | |